Get the Stockscreener App
2.87
2.38%
-0.07
After Hours:
2.84
-0.03
-1.05%
Onconetix Inc stock is traded at $2.87, with a volume of 45,623.
It is down -2.38% in the last 24 hours and down -9.46% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
See More
Previous Close:
$2.94
Open:
$2.99
24h Volume:
45,623
Relative Volume:
0.07
Market Cap:
$4.44M
Revenue:
-
Net Income/Loss:
$-53.12M
P/E Ratio:
-0.0264
EPS:
-108.8
Net Cash Flow:
$-15.86M
1W Performance:
-4.33%
1M Performance:
-9.46%
6M Performance:
-84.99%
1Y Performance:
-99.34%
1-Day Range:
$2.82
$3.04
1-Week Range:
$2.82
$3.04
52-Week Range:
$2.61
$552.50
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Compare ONCO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
2.87 | 4.53M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Onconetix Inc Stock (ONCO) Latest News
Custom watchlist performance reports with Onconetix Inc.Layoff News & Free Community Supported Trade Ideas - Newser
Real time scanner hits for Onconetix Inc. explainedWeekly Stock Report & Fast Gaining Stock Reports - Newser
Regression analysis insights on Onconetix Inc. performanceMarket Sentiment Summary & High Conviction Buy Zone Picks - Newser
Published on: 2025-09-03 05:07:12 - Newser
Why Onconetix Inc. is moving todayJuly 2025 Review & Safe Capital Investment Plans - Newser
Is now a turning point for Onconetix Inc.Quarterly Trade Summary & Consistent Profit Trading Strategies - Newser
What high frequency data says about Onconetix Inc.2025 Investor Takeaways & Safe Investment Capital Preservation Plans - Newser
Trend analysis for Onconetix Inc. this week2025 Trading Recap & Growth Focused Entry Reports - Newser
Quantitative breakdown of Onconetix Inc. recent moveJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - Newser
Onconetix Director Resignation Amid Financial Adjustments - MSN
Applying big data sentiment scoring on Onconetix Inc.Quarterly Risk Review & Daily Risk Controlled Trade Plans - Newser
Is this a good reentry point in Onconetix Inc.Market Sentiment Summary & Proven Capital Preservation Methods - Newser
Is Onconetix Inc. stock ready for a breakoutJuly 2025 Drop Watch & Low Drawdown Trading Techniques - Newser
Is Onconetix Inc. forming a bottoming base2025 Market Overview & Fast Moving Stock Watchlists - Newser
Tick level data insight on Onconetix Inc. volatility2025 Top Gainers & Smart Allocation Stock Tips - Newser
Oncopeptides ABNew real-world data confirms efficacy and safety of Pepaxti, presented at IMS Annual Meeting - MarketScreener
Using R and stats models for Onconetix Inc. forecasting2025 Institutional Moves & Accurate Trade Setup Notifications - Newser
Intraday pattern recognizer results for Onconetix Inc.Price Action & Daily Oversold Stock Bounce Ideas - Newser
Earnings visualization tools for Onconetix Inc.Quarterly Risk Review & Daily Chart Pattern Signal Reports - Newser
What to expect from Onconetix Inc. in the next 30 daysTrade Ideas & Stepwise Trade Signal Implementation - Newser
MACD Cross Could Confirm Trend in Onconetix Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Can Onconetix Inc. deliver consistent dividends2025 Analyst Calls & Weekly Setup with High ROI Potential - khodrobank.com
What’s the analyst consensus on Onconetix Inc.July 2025 Sector Moves & Fast Gaining Stock Reports - khodrobank.com
Real time pattern detection on Onconetix Inc. stock2025 Analyst Calls & Low Risk High Reward Ideas - Newser
Is This a Bottoming Phase for Onconetix Inc. getLinesFromResByArray error: size == 0 - sisaissue.com
Aug Retail: What is Onconetix Inc. s 5 year growth outlookDip Buying & Low Risk Entry Point Tips - khodrobank.com
Using data models to predict Onconetix Inc. stock movementJuly 2025 Momentum & AI Powered Market Trend Analysis - Newser
Building trade automation scripts for Onconetix Inc.Weekly Stock Report & Free High Return Stock Watch Alerts - Newser
What machine learning models say about Onconetix Inc.July 2025 Momentum & Weekly Stock Performance Updates - Newser
Published on: 2025-08-31 16:18:09 - Newser
Top chart patterns to watch in Onconetix Inc.2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - Newser
Will earnings trigger a reversal in Onconetix Inc.2025 Stock Rankings & AI Enhanced Execution Alerts - Newser
Guidance Update: Is Onconetix Inc. in a long term uptrendEarnings Miss & AI Optimized Trading Strategy Guides - sundaytimes.kr
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):